54 related articles for article (PubMed ID: 1157063)
21. [Further advances in the topical diagnosis of ischemic myocardial lesions in vivo].
Málek P; Vavrejn B; Ratuský J; Kolc J; Kronrád L
Cas Lek Cesk; 1966 Nov; 105(47):1273-8. PubMed ID: 5979879
[No Abstract] [Full Text] [Related]
22. [The effect of glutamic and aspartic acid on collateral circulation and oxygen tension in the myocardium].
Sapozhkov AV
Patol Fiziol Eksp Ter; 1968; 12(5):20-3. PubMed ID: 5747630
[No Abstract] [Full Text] [Related]
23. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
Nakaya H
Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
[TBL] [Abstract][Full Text] [Related]
24. [The effects of dopamine and amrinone on myocardial oxygen demand-supply relationship in dogs with coronary artery stenosis].
Fujigaki T
Masui; 1989 Jan; 38(1):41-52. PubMed ID: 2709608
[TBL] [Abstract][Full Text] [Related]
25. [The effect of carbon dioxide on oxygen tension in different zones of the myocardium during local ischemia].
Sanotskaia NV
Fiziol Zh SSSR Im I M Sechenova; 1970; 56(7):1033-42. PubMed ID: 5504491
[No Abstract] [Full Text] [Related]
26. [Effect of sodium oxybutyrate on the blood supply and activity of the normal and ischemic myocardium].
Chichkanov GG; Bogolepov AK; Tsorin IB; Matsievskiĭ DD
Biull Eksp Biol Med; 1982 Mar; 93(3):44-7. PubMed ID: 7093482
[TBL] [Abstract][Full Text] [Related]
27. [Myocardial reperfusion injury. The role of free radicals and xanthine oxidase].
Kopacz M; Firek L; Ilmurzyńska K
Kardiol Pol; 1991; 34(5):309-16. PubMed ID: 1921116
[No Abstract] [Full Text] [Related]
28. [Correction of contractile function and metabolism in canine ischemic myocardium due to exogenous glutamic acid].
Pisarenko OI; Novikova EB; Serebriakova LI; Tskitishvili OV; Ivanov VE
Biull Eksp Biol Med; 1985 Sep; 100(9):280-2. PubMed ID: 2864092
[TBL] [Abstract][Full Text] [Related]
29. [The effect of pituitrin on myocardial blood supply and oxygen tension].
Sanotskaia NV
Fiziol Zh SSSR Im I M Sechenova; 1973 Mar; 59(3):450-8. PubMed ID: 4775079
[No Abstract] [Full Text] [Related]
30. [Mechanisms of verapamil prevention of disorders of cardiac contractile function during ischemia and reperfusion].
Bratus' VV; Bezus'ko AG; Shabaran SS; Filonenko VV
Patol Fiziol Eksp Ter; 1989; (5):26-9. PubMed ID: 2616210
[TBL] [Abstract][Full Text] [Related]
31. Uptake of 203Hg-hydroxy-mercury-fluorescein in myocardial infarcts.
Ramanathan P; Ganatra RD; Daulatram K; Sen PK; Blau M
J Nucl Med; 1971 Sep; 12(9):641-3. PubMed ID: 5571890
[No Abstract] [Full Text] [Related]
32. [The effect of the duration of coronary occlusion on the healing of an experimental myocardial infarct].
Syroïd DV; Sokrut VM; Shvyrenko IR
Fiziol Zh (1994); 1999; 45(6):26-30. PubMed ID: 10687078
[TBL] [Abstract][Full Text] [Related]
33. Metabolic disarrangement in ischemic heart disease and its therapeutic control.
Ferrari R
Rev Port Cardiol; 1998 Sep; 17(9):667-84. PubMed ID: 9834638
[TBL] [Abstract][Full Text] [Related]
34. [Studies on influence of dextran sulphate upon myocardial metabolism].
Hattori K
Jpn Circ J; 1966 Apr; 30(4):405-33. PubMed ID: 5952395
[No Abstract] [Full Text] [Related]
35. [The inhibitory effect of mercury compounds on human malignant growth. III. A histological follow-up study].
MIYAJI S; SONEHARA S; HOSODA T; MUKAI H; SHINOMIYA M; NAKAMURA N
Gan; 1956 Dec; 47(3-4):406-9. PubMed ID: 13415058
[No Abstract] [Full Text] [Related]
36. [Complex effect of mercurascan on ischaemia-induced myocardial injury].
Málek P; Kolc J; Vrána M; Kucerová V; Mrhová O; Vránová Z
Cas Lek Cesk; 1975 Jun; 114(25):753-7. PubMed ID: 1157063
[No Abstract] [Full Text] [Related]
37. Studies on the therapeutic use of mercurascan (MSC). Part 1: Distribution of mercurascan in the body in experimental and clinical myocardial ischaemia.
Málek P; Vavrejn B; Kolc J; Ratuský J
Int J Clin Pharmacol; 1974 Dec; 10(4):266-72. PubMed ID: 4443131
[No Abstract] [Full Text] [Related]
38. Studies on the therapeutic use of mercurascan (MSC). Part 2: Antiarrhythmogenic and haemodynamic effect of MSC in experimental myocardial ischaemia.
Málek P; Vrána M; Kolc J; Netusil M; Blazek Z
Int J Clin Pharmacol; 1974 Dec; 10(4):273-82. PubMed ID: 4140846
[No Abstract] [Full Text] [Related]
39. Studies on the therapeutic use of Mercurascar. Part IV: The effect of Mercurascan on some metabolic changes in experimental myocardial ischaemia. Section II: Enzymes.
Mrhová O; Kolc J; Málek P
Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):52-7. PubMed ID: 125244
[No Abstract] [Full Text] [Related]
40. Nifedipine for angina and acute myocardial ischaemia.
Hugenholtz PG; Verdouw PD; de Jong JW; Serruys PW
Postgrad Med J; 1983; 59 Suppl 2():40-58. PubMed ID: 6351043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
